ECG signal power vector detection of ischemia or infarction

• US 7,894,889 B2
• Filed: 06/12/2009
• Issued: 02/22/2011
• Est. Priority Date: 01/30/2006
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Zhang, Yi
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): Porter, Jr.; Gary A
• Application Number:
  US12/484,061
• Publication Number:
  US 20090247888A1
• Time in Patent Office: 620 Days
• Field of Search: 600/508, 600/512, 600/517
• US Class Current: 600/512
• CPC Class Codes: A61B 5/341 Vectorcardiography [VCG]
• CPC Class Codes: A61B 5/349 Detecting specific parameters of the electrocardiograph cycle
• CPC Class Codes: A61B 5/7207 of noise induced by motion artifacts
• CPC Class Codes: A61B 5/7285 for synchronising or triggering a physiological measurement or image acquisition with a physiological event or waveform, e.g. an ECG signal A61B6/5205, A61B6/541, A61B8/5207, A61B8/543 take precedence

Abstract

A method comprising sensing at least one cardiac signal representative of cardiac activity of a subject using an implantable medical device (IMD), calculating, from the cardiac signal, a first dominant vector corresponding to a direction and magnitude of maximum signal power of an ST-T first segment of a cardiac cycle and a second dominant vector corresponding to a direction and magnitude of maximum signal power of a P-QRS second segment of a cardiac cycle, measuring a change in the first dominant vector, measuring a change in the second dominant vector, and subtracting the change in the second dominant vector from the measured change in the first dominant vector to form a difference.

Claims

1. A method comprising:

sensing at least one cardiac signal representative of cardiac activity of a subject using an implantable medical device (IMD);

calculating, from the cardiac signal, a first dominant vector corresponding to a direction and magnitude of maximum signal power of an ST-T first segment of a cardiac cycle and a second dominant vector corresponding to a direction and magnitude of maximum signal power of a P-QRS second segment of a cardiac cycle, wherein the P-QRS segment includes the P-wave and extends to and includes the S-wave;

measuring a change in the first dominant vector;

measuring a change in the second dominant vector;

subtracting the change in the second dominant vector from the measured change in the first dominant vector to form a difference; and

deeming an ischemic event to have occurred at least in part from whether the difference exceeds a specified threshold value.

2. The method of claim 1, further including activating an alarm indicative of the deemed ischemic event.

3. The method of claim 1, wherein deeming an ischemic event to have occurred further includes deeming an ischemic event if the difference exceeds the specified threshold value in X of Y consecutive cardiac cycles, wherein X and Y are integers and X is less than or equal to Y.

4. The method of claim 1, comprising establishing a baseline vector for at least one of the first and second dominant vectors and measuring a change from the baseline vector.

5. The method of claim 4, wherein establishing a baseline vector includes calculating a central tendency for at least one of the first and second dominant vectors.

6. The method of claim 4, comprising reducing noise related to posture by subtracting the measured change in the second dominant vector from the measured change in the first dominant vector to form a difference.

7. The method of claim 4, wherein measuring the change from the baseline vector includes:

subtracting a first baseline vector from a later-measured first dominant vector to obtain a first change representative of a change due to posture during the first segment;

subtracting a second baseline vector from a later-measured second dominant vector to obtain a second change representative of a change due to posture and ischemia during the second segment; and

subtracting the first change from the second change to obtain a third change representative of a change due to ischemia.

8. The method of claim 4, comprising measuring a trend in at least one of the first and second dominant vectors.

9. The method of claim 8, including storing an ischemia indication using the measured trend.

10. The method of claim 1, wherein measuring a change in the first dominant vector and measuring a change in the second dominant vector comprises measuring at least one of a change in angle, a change in magnitude, a variance of the angle or the magnitude, a power spectral density, a rate of change of the angle, a rate of change of the magnitude, and a rate of change of the variance of the angle or the magnitude.

11. The method of claim 1, further including deeming an ischemic event to have occurred from whether the difference exceeds a specified threshold value in combination with a measured output from one or more sensors.

12. The method of claim 11, wherein deeming an ischemic event to have occurred includes blending the output of at least one sensor and the difference according to at least one rule.

13. The method of claim 1, wherein sensing a cardiac signal includes sensing a cardiac signal approximating a surface electrocardiogram (ECG).

14. A system comprising

an implantable medical device (IMD) comprising:

a plurality of implantable electrodes adapted for spatial distribution within a subject; and

at least one cardiac signal sensing circuit in communication with the electrodes, the cardiac signal sensing circuit operable to produce an electrical cardiac signal representative of cardiac activity of the subject; and

means for calculating, from the electrical cardiac signal, a first dominant vector corresponding to a direction and magnitude of maximum signal power of an ST-T first segment of at least one cardiac cycle of the subject and at least a second dominant vector corresponding to a direction and magnitude of maximum signal power of a P-QRS second segment of the cardiac cycle, wherein the P-QRS segment includes the P-wave and extends to and includes the S-wave, and forming a difference by subtracting a measured change in the second dominant vector from a measured change in the first dominant vector, and using the difference to reduce noise in the measured change in the first dominant vector.

15. The system of claim 14, further including means to create trend data of changes in at least one dominant vector.

16. The system of claim 14, further including means for communicating the trend data to a network server system.

17. The system of claim 14, wherein the means for calculating is further configured to:

establish first and second baseline vectors for the first and second dominant vectors; and

measure a change in a dominant vector relative to a baseline vector.

18. The system of claim 17, wherein the means for calculating is further configured to:

subtract the first baseline vector from a later-measured first dominant vector to obtain a first change representative of a change due to posture during the first segment;

subtract the second baseline vector from a later-measured second dominant vector to obtain a second change representative of a change due to posture and ischemia during the second segment; and

subtract the first change from the second change to obtain a third change representative of a change due to ischemia.

19. The system of claim 17, wherein the wherein the means for calculating is further configured to measure a change in a dominant vector by measuring at least one of a change in angle, a change in magnitude, a variance of the angle or the magnitude, a power spectral density, a rate of change of the angle, a rate of change of the magnitude, and a rate of change of the variance of the angle or the magnitude.